KIM SCHAFER: Open Payments
NPI 1912957291 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$77,912 in 96 payments from 10 companies in 2025. Trend: 2023 $62,896 · 2024 $70,044 · 2025 $77,912
Speaker / faculty: $44,597Travel & lodging: $16,245Consulting: $14,813Food & beverage: $2,257
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 38 | $40,655 |
| PFIZER INC. | 22 | $15,249 |
| SANOFI US SERVICES INC. | 1 | $7,380 |
| CSL Behring | 12 | $6,001 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $4,534 |
| GENZYME CORPORATION | 8 | $2,838 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $723 |
| Genentech, Inc. | 4 | $275 |
| Genentech USA, Inc. | 2 | $189 |
| Octapharma USA, Inc. | 1 | $69 |
Products named: HYMPAVZI, Alhemo, ALTUVIIIO, Jivi, HEMGENIX, Idelvion, QFITLIA, ADVATE.
Industry payments across CA — which companies pay providers there.
